Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved.

MLA

Kerbel, Robert S. “Human Tumor Xenografts as Predictive Preclinical Models for Anticancer Drug Activity in Humans: Better than Commonly Perceived-but They Can Be Improved.” Cancer Biology & Therapy, vol. 2, no. 4 Suppl 1, July 2003, pp. S134–39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14508091&authtype=sso&custid=ns315887.

APA

Kerbel, R. S. (2003). Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved. Cancer Biology & Therapy, 2(4 Suppl 1), S134–S139.

Chicago

Kerbel, Robert S. 2003. “Human Tumor Xenografts as Predictive Preclinical Models for Anticancer Drug Activity in Humans: Better than Commonly Perceived-but They Can Be Improved.” Cancer Biology & Therapy 2 (4 Suppl 1): S134–39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14508091&authtype=sso&custid=ns315887.